5 European Projects Found
Searched on 125080 European Projects
FINISHED
iABC Programme (IABC PROGRAMME)
Start date: Aug 1, 2015, End date: Jul 31, 2020,
Cystic Fibrosis (CF) is a common fatal inherited disease with a frequency of 1 in 2500 live births, affecting approximately 36,000 (0.737/10,000) people in the EU. Chronic bacterial pulmonary infection leading to an irreversible decline in lung structure and function is the main cause of mortality and morbidity in patients with CF, with more than 95% of deaths due to respiratory failure. Pseudomon ...
Read Project
21
Partners Participants
FINISHED
Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities (ETOX)
Start date: Jan 1, 2010, End date: Dec 31, 2016,
The eTOX consortium proposes to develop innovative methodological strategies and novel software tools to better predict the toxicological profiles of new molecular entities in early stages of the drug development pipeline. This will be achieved by coordinating the efforts of specialists from academia and SMEs in the wide scope of disciplines that are required to move towards a more reliable modell ...
Read Project
30
Partners Participants
FINISHED
Breast Cancer Somatic Genetics Study (BASIS)
Start date: Jul 1, 2010, End date: Dec 31, 2014,
"All cancers arise due to somatically acquired mutations in their genomes which alter the function of key cancer genes. Understanding these critical mutational events underlying cancer development is paramount for advancing prevention, early detection, monitoring and treatment of the disease. Breast cancer is the most common class of cancer diagnosed in women worldwide with more than one million c ...
Read Project
16
Partners Participants
FINISHED
Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors (UROMOL)
Start date: Feb 1, 2008, End date: Jul 31, 2013,
"Bladder cancer is a recurrent and very prevalent cancer and it generates the highest cost per patient in Europe. New genomic methods have allowed identifying new markers with potential clinical application. However, due to the use of single-marker assays and poor study design, none of these markers has made it to the clinic. FGFR3 and PIK3CA mutations, expression profiles, and microsatellite alte ...
Read Project
8
Partners Participants
FINISHED
European Life-science Infrastructure for Biological Information (ELIXIR)
Start date: Nov 1, 2007, End date: Dec 31, 2012,
"The objective of the ELIXIR preparatory phase is to produce a memorandum or memoranda of understanding between organisations (government agencies, research councils, funding bodies and scientific organisations) within the member states, with the purpose of constructing a world class and globally positioned European infrastructure for the management and integration of information in the life scien ...
Read Project
